ARYx Therapeutics Provides Update on Product Development -- Reports Results for 2007 Third Quarter.
Business Wire (December 20, 2007)
Financial report
Permanent Link:
http://vlex.com/vid/aryx-therapeutics-provides-update-2007-56233705
Id. vLex: VLEX-56233705
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
ARYx Therapeutics Provides Update on Product Development -- Reports Results for 2007 Third Quarter.
FREMONT, Calif. -- ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company, today provided an update on the development of their products and reported financial results for the three and nine months ended September 30, 2007.
Highlights for the Quarter The highlights in the development of our products are: ATI-7505, a prokinetic agent for the treatment of upper and lower gastrointestinal disorders * Our partner Procter & Gamble Pharmaceuticals (P&G) is conducting a standard cardiac safety study under a special protocol assessment with the Food and Drug Administration. The results are expected in the first half of 2008;...Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
